Assessing participant responses from over 18,000 cases entered into the HepB Consult tool at the time of analysis, these findings highlight important knowledge gaps in the information needed to make appropriate HBV management decisions. It also demonstrates differences between healthcare providers’ approaches and the AASLD guideline recommendations.
Presented at IDWeek 2020.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.